[An approach to the psychiatric manifestations of alcoholism].
The authors of this article, confronted with the frequent and common emergencies associated with the "alcoholic's" behavioral changes-whether he be a symptomatic drinker, an episodic excessive drinker, or a chronic alcoholic-tested an original molecule belonging to the group of alkylsulfone-0-anisamides (triaprid) on twenty patients hospitalized in a general medical service. The results were very encouraging, showing an improvement of numerous symptoms,in patrticular, tremors, diverse pain, and aggressiveness. The authors note that daily doses of 300 to 400 mg of the modification were well tolerated.
D000328:Adult; D000368:Aged; D000430:Alcohol Withdrawal Delirium / Q000188:drug therapy; D000437:Alcoholism / Q000188:drug therapy* / Q000523:psychology; D001549:Benzamides / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011604:Psychoses, Alcoholic / Q000188:drug therapy*
D001549:Benzamides
Une approche des manifestations psychiatriques de l'éthylisme.